Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma

Chand Raja, Peter Graham, Syed Rizvi, +9

Cancer Biology & Therapy

Glycogen Synthase Kinase-3<i>β</i> Inhibition Preserves Hematopoietic Stem Cell Activity and Inhibits Leukemic Cell Growth

Tiffany Holmes, Tracey O’Brien, Robert J. Knight, +5

Stem Cells

GSK-3β Inhibition Promotes Engraftment of Ex Vivo-Expanded Hematopoietic Stem Cells and Modulates Gene Expression

Kap‐Hyoun Ko, Tiffany Holmes, Patricia Palladinetti, +4

Stem Cells

Stem Cell MigrationStem Cell BiologyRegenerative MedicineCell Cycle TimeStem Cell Mobilization +17

Targeted alpha therapy for cancer

Barry Allen, Chand Raja, Syed Rizvi, +8

Physics in Medicine and Biology

Bismuth-213 radioimmunotherapy with C595 anti–MUC1 monoclonal antibody in an ovarian cancer ascites model

Emma Song, Chang Qu, Syed Rizvi, +7

Cancer Biology & Therapy

Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs

Shruthi Subramanian, Julie A.I. Thoms, Yizhou Huang, +26

Blood

Pre-clinical Study of 213Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer

Chang Qu, Emma Song, Yong Li, +5

Clinical & Experimental Metastasis

Tumor BiologyPancreatic CancerGastrointestinal OncologyMedicinePathology +6

Glycogen synthase kinase−3β inhibitors suppress leukemia cell growth

Emma Song, Patricia Palladinetti, Guy Klamer, +4

Experimental Hematology

Hematological MalignancyLeukemia Cell GrowthCell RegulationMedicineCell Biology +2

The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy

Emma Song, Syed Meraj Azhar Rizvi, Chang Qu, +6

Physics in Medicine and Biology

Immunocytochemical TechniqueBiological DosimeterRadiation EffectImmunologyRadiation Exposure +22

Pharmacokinetics and toxicity of 213Bi-labeled PAI2 in preclinical targeted alpha therapy for cancer

Emma Song, Syed Rizvi, Chang Qu, +4

Cancer Biology & Therapy